Contact

Marta Acilu

Marta Acilu / Julio Font

• Biopharmaceutical company dedicated to the development and commercialization of new medical devices, active ingredients and cell therapy drugs in the field of Regenerative Medicine.
• Therapeutic approach focused on the protection and regeneration of tissues damaged by oxidative and inflammatory environments, backed up by a strong industrial protection with 46 patents so far. Looking for commercial partners for the distribution of its main medical device REOXCARE® for wound care.

REOXCARE®. Antioxidant wound dressing for hard to heal wounds. First dressing that addresses the key factor of antioxidation as an accelerator of natural healing of chronic wounds. Benefits proved in post marketing studies, showing health and economic advantages, saving over 50% of treatment cost comparing to conventional treatments.

• Histocell.
• Reoxcare.